Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

BioNTech (BNTX) to Announce Q1 2025 Financial Results

BioNTech (BNTX) Advances Cancer Treatment Trials and IP Defense

Q1 Earnings Forecast for BioNTech Issued By Leerink Partnrs

Marshall Wace LLP Increases Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE to Announce Q1 2025 Financial Results | BNTX stock news

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 | The Manila Times

BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations

Bridgewater Associates LP Increases Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE (NASDAQ:BNTX) Shares Sold by Capital International Inc. CA

Finward Bancorp Makes New Investment in BioNTech SE (NASDAQ:BNTX)

What the Newest mRNA Vaccines Could Do Beyond COVID
BioNTech (NasdaqGS:BNTX) Sees 11% Stock Increase Over Last Week

BioNTech (BNTX) Dominates German Stocks Among Hedge Funds

BioNTech SE (NASDAQ:BNTX) Shares Sold by Quinn Opportunity Partners LLC

Scotia Capital Inc. Acquires 30,143 Shares of BioNTech SE (NASDAQ:BNTX)

Sen. Johnson demands COVID vaccine makers hand over all documents, communications, as evidence against their products reaches a climax - NaturalNews.com

Franklin Resources Inc. Buys 133,402 Shares of BioNTech SE (NASDAQ:BNTX)

Cinctive Capital Management LP Buys Shares of 14,760 BioNTech SE (NASDAQ:BNTX)

Is BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds?

BioNTech (NASDAQ:BNTX) Price Target Cut to $145.00 by Analysts at HC Wainwright

Groupama Asset Managment Buys 19,994 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Brokerages

BioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?

Analysts' Top Healthcare Picks: Ascentage Pharma Group International Unsponsored ADR (AAPG), BioNTech SE (BNTX) | Markets Insider

Mitsubishi UFJ Trust & Banking Corp Has $21.37 Million Position in BioNTech SE (NASDAQ:BNTX)

CureVac (CVAC) Rises 10% After Key Patent Victory; Other Movers

European Patent Office declares CureVac mRNA patent valid

CureVac (CVAC) Surges as European Court Validates Key Patent

CORRECT: CureVac Says Patent Validated in Dispute With BioNTech

Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts